Cardinal Health, Inc. [CAH] stock is trading at $107.17, up 0.13%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CAH shares have lost -0.83% over the last week, with a monthly amount drifted -3.11%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cardinal Health, Inc. [NYSE: CAH] stock has seen the most recent analyst activity on February 26, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $125. Previously, Argus upgraded its rating to Buy on February 09, 2024. On January 03, 2024, Barclays initiated with a Overweight rating and assigned a price target of $117 on the stock. Wells Fargo started tracking the stock assigning a Underweight rating and suggested a price target of $96 on December 14, 2023. Evercore ISI downgraded its rating to a In-line but $100 remained the price target by the analyst firm on July 10, 2023. Citigroup started tracking with a Neutral rating for this stock on March 31, 2023, and assigned it a price target of $77. In a note dated February 03, 2023, Robert W. Baird upgraded an Outperform rating on this stock and boosted its target price from $87 to $94.
Cardinal Health, Inc. [CAH] stock has fluctuated between $77.56 and $116.04 over the past year. Currently, Wall Street analysts expect the stock to reach $81.2 within the next 12 months. Cardinal Health, Inc. [NYSE: CAH] shares were valued at $107.17 at the most recent close of the market. An investor can expect a potential drop of -24.23% based on the average CAH price forecast.
Analyzing the CAH fundamentals
Cardinal Health, Inc. [NYSE:CAH] reported sales of 216.15B for the trailing twelve months, which represents a growth of 11.61%. Gross Profit Margin for this corporation currently stands at 0.03% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is -0.21 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 106.71 points at the first support level, and at 106.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 107.82, and for the 2nd resistance point, it is at 108.47.
Ratios To Look Out For
For context, Cardinal Health, Inc.’s Current Ratio is 0.98. As well, the Quick Ratio is 0.50, while the Cash Ratio is 0.12. Considering the valuation of this stock, the price to sales ratio is 0.12 and price to earnings (TTM) ratio is 42.19.
Transactions by insiders
Recent insider trading involved WEITZMAN DEBORAH, CEO, Pharmaceutical Segment, that happened on Nov 27 ’23 when 36642.0 shares were sold. CEO, Pharmaceutical Segment, WEITZMAN DEBORAH completed a deal on Aug 28 ’23 to sell 6712.0 shares. Meanwhile, Chief Accounting Officer Scherer Mary C. sold 20695.0 shares on Aug 18 ’23.
